These data indicate that interference with Slc15A2-mediated dipeptide uptake, either by non-metabolizable analogue or chemical competitor, attenuates mTORC1-mediated nutrient signalling in LT-CML stem cells. This evidence concerns the gene SLC15A2 and chronic myelogenous leukemia, BCR-ABL1 positive.